| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497333C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them |
| 06/10/2009 | CN100496472C Topical compositions and methods for treating pain |
| 06/09/2009 | US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor |
| 06/09/2009 | US7544701 Central nervous system disorders; psychological disorders |
| 06/09/2009 | US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders |
| 06/09/2009 | US7544690 MCH receptor antagonists |
| 06/09/2009 | US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544681 with organic acids selected to reduce the side effects induced by the psychotropic drugs and/or to exert anti-proliferative activity |
| 06/09/2009 | US7544680 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide (CGRP) receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma |
| 06/09/2009 | US7544676 Sulfamoyl benzamides and methods of their use |
| 06/09/2009 | US7544669 Polynucleotide therapy |
| 06/09/2009 | US7544509 Method for preparing stem cell preparations |
| 06/09/2009 | US7544497 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/09/2009 | CA2377167C Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 06/09/2009 | CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070733A1 Peripheral phenolic opioid antagonist |
| 06/04/2009 | WO2009070584A1 Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | WO2009070583A1 Pyrido[3,2-e]pyrazines, process for preparing the same, and their use as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009070328A1 Modulators of the epidermal growth factor receptor (egfr) pathway for use in the treatment or prevention of substance abuse |
| 06/04/2009 | WO2009070311A2 Crystal forms of o-desmethylvenlafaxine fumarate |
| 06/04/2009 | WO2009069828A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease |
| 06/04/2009 | WO2009069764A1 Opioid analgesic agent |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009069610A1 Fused indane compound |
| 06/04/2009 | WO2009069126A1 Compositions comprising nicotinic agonists and methods of using same |
| 06/04/2009 | WO2009068668A1 New therapeutic approaches for treating cmt and related disorders |
| 06/04/2009 | WO2009068595A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/04/2009 | WO2009068520A2 Polymorphic form of rotigotine |
| 06/04/2009 | WO2009068335A1 Human monoclonal nicotine specific antibodies |
| 06/04/2009 | WO2009068320A1 Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 06/04/2009 | WO2009068042A2 Novel peptides derived from ncam (fgls) |
| 06/04/2009 | WO2009040022A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009038879A3 Stem cell differentiating agents and uses therefor |
| 06/04/2009 | WO2009035634A3 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 06/04/2009 | WO2009033815A3 Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent |
| 06/04/2009 | WO2009033734A3 Use of a peptide as a therapeutic agent |
| 06/04/2009 | WO2009033657A3 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | WO2009019503A3 P2x7 antagonists for use in the treatment of mood disorders |
| 06/04/2009 | WO2009007300A3 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 06/04/2009 | WO2008155669A3 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 06/04/2009 | WO2008143880A3 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and traumatic brain injury |
| 06/04/2009 | US20090143474 Reduced dose intravenous acetaminophen |
| 06/04/2009 | US20090143464 Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143450 Method for treating central pain syndrom or for inducing centrally generated pain in an animal model |
| 06/04/2009 | US20090143441 Combination therapies of Thiazolidinedione analogues |
| 06/04/2009 | US20090143440 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143437 Ep4 receptor antagonists |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 06/04/2009 | US20090143433 Cocktail for modulation of alzheimer's disease |
| 06/04/2009 | US20090143429 Quinoline Derivatives as Neurokinin Receptor Antagonists |
| 06/04/2009 | US20090143421 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 06/04/2009 | US20090143420 2-benzoylimidazopyridine derivatives, preparation and therapeutic use thereof |
| 06/04/2009 | US20090143415 Tetrodotoxin And Its Derivatives For The Treatment Of Central-Nervously Derived Neuropathic Pain |
| 06/04/2009 | US20090143406 New Phenylpiperazine |
| 06/04/2009 | US20090143403 Methods for Administering Aripiprazole |
| 06/04/2009 | US20090143402 Isoquinolinone derivatives as nk3 antagonists |
| 06/04/2009 | US20090143394 Compounds for activating tgf-beta signaling |
| 06/04/2009 | US20090143391 Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10 |
| 06/04/2009 | US20090143388 Treatment of brain disorders |
| 06/04/2009 | US20090143387 Sustained-release tablet composition |
| 06/04/2009 | US20090143382 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 06/04/2009 | US20090143380 2h- or 3h-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof |
| 06/04/2009 | US20090143376 Fused Heterocyclic Compounds and Their Use as Sirtuin Modulators |
| 06/04/2009 | US20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143371 Isoxazole-pyridine derivatives |
| 06/04/2009 | US20090143367 8-chloro-3,4-dimethyl-1-(2- methylphenyl)imidazo[1,5- a]quinoxaline; inhibitors of phosphodiesterase 10; for treatment of central nervous system disorders (cognitive deficits, social phobia, reduced vigilance, obesity and psychosis) |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | US20090143363 Deuterated lorcaserin |
| 06/04/2009 | US20090143362 Carbamazepine formulations |
| 06/04/2009 | US20090143361 Pyrido[3,2-E]Pyrazines, Process For Preparing The Same, And Their Use As Inhibitors Of Phosphodiesterase 10 |
| 06/04/2009 | US20090143360 Oxcarbazepine Formulation |
| 06/04/2009 | US20090143358 Inhibitors of ion channels |
| 06/04/2009 | US20090143350 Anxiolytic Marcgraviaceae Compositions Containing Betulinic Acid, Betulinic Acid Derivatives, and Methods |
| 06/04/2009 | US20090143347 Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depressive disorders and long-term neurological diseases |
| 06/04/2009 | US20090143335 Modified absorption formulation of gaboxadol |
| 06/04/2009 | US20090143332 Cyclodextrin Cyanohydrins |
| 06/04/2009 | US20090143304 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143293 Peptide inhibitors of protein kinase C gamma for pain management |
| 06/04/2009 | US20090143281 Thrombomodulin analogs for use in recovery of spinal cord injury |
| 06/04/2009 | US20090143279 Methods and compositions for treating metabolic disorders |
| 06/04/2009 | US20090142834 Multipotent stem cells from peripheral tissues and uses thereof |
| 06/04/2009 | US20090142831 Placental stem cells |